• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Prev Alzheimers Dis . Trends in cognitive impairment among older adults in China from 2002 to 2022: Evaluating the impact of the COVID-19 pandemi

tetano

Editor, Senior Moderator
J Prev Alzheimers Dis


. 2025 Sep 19:100370.
doi: 10.1016/j.tjpad.2025.100370. Online ahead of print. Trends in cognitive impairment among older adults in China from 2002 to 2022: Evaluating the impact of the COVID-19 pandemic

Lei Feng[SUP] 1 [/SUP], Kaisy Xinhong Ye[SUP] 2 [/SUP], Qiushi Feng[SUP] 3 [/SUP], Yan Mo[SUP] 3 [/SUP], Zuqi Cai[SUP] 3 [/SUP], Chunbo Li[SUP] 4 [/SUP], Jintai Yu[SUP] 5 [/SUP], Bin Li[SUP] 6 [/SUP], Andrea B Maier[SUP] 7 [/SUP], Yi Zeng[SUP] 8 [/SUP], Zhenglian Wang[SUP] 9 [/SUP]



Affiliations
Free article Abstract

Background: Cognitive impairment is a growing public health concern, particularly in aging populations. While trends in CI prevalence in China were studied up to 2018, no previous research has explored how the COVID-19 pandemic has affected these trends.
Objectives: This study aims to extend the analysis to 2022, examining the impact of the pandemic on cognitive impairment prevalence.
Participants: The Chinese Longitudinal Healthy Longevity Survey (CLHLS) data across multiple waves (2002 to 2022) was used (n=64,872).
Measurements: Cognitive impairment was assessed using a Chinese version of the Mini-Mental State Examination (MMSE). The rural/urban-sex-single age-specific prevalence of cognitive impairment across different waves were estimated using the DemoRates R package. Cognitive impairment trends before and after the onset of the COVID-19 pandemic were compared to identify any significant changes.
Results: In 2018 and previous waves, an average of 16,191 participants per wave were surveyed (four waves), with a cognitive impairment prevalence of 4.3%. In 2022, post-COVID-19, the survey included 14,022 participants and showed a significant increase in CI prevalence to 6.8%. The observed trends were independent of gender, age group, and residential environment (P-trend < 0.001). However, a significant decrease in mean calf circumference, increase in proportion of overweight participants, and increases in daily fruit and vegetable intake and regular physical activity were notable after the pandemic.
Conclusion: The study suggests that the COVID-19 pandemic may have contributed to the observed increase in cognitive impairment prevalence in China, underscoring the importance of further research into the long-term cognitive effects of global health crises. These findings highlight the need to strengthen healthcare systems to support cognitive health in an aging population, while considering both pandemic-related and ongoing factors in the management of cognitive impairment.

Keywords: China; Cognitive impairment; Coronavirus; Pandemic; Prevalence.

 
Back
Top